U.S. markets closed

Aerie Pharmaceuticals, Inc. (AERI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.83-0.14 (-0.74%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/9/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
890.02M632.56M551.17M686.54M627.43M
Enterprise Value 3
875.16M634.88M524.22M632.08M524.49M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
9.967.456.598.478.77
Price/Book (mrq)
35.3110.536.145.403.76
Enterprise Value/Revenue 3
10.5325.7226.1135.0525.79
Enterprise Value/EBITDA 7
-7.47-25.38-21.58-18.98-15.15

Trading Information

Stock Price History

Beta (5Y Monthly) 0.72
52-Week Change 324.62%
S&P500 52-Week Change 349.51%
52 Week High 321.30
52 Week Low 39.01
50-Day Moving Average 318.65
200-Day Moving Average 314.63

Share Statistics

Avg Vol (3 month) 3714.38k
Avg Vol (10 day) 3494.13k
Shares Outstanding 546.92M
Implied Shares Outstanding 6N/A
Float 45.8M
% Held by Insiders 12.36%
% Held by Institutions 1103.61%
Shares Short (Mar 14, 2021) 47.05M
Short Ratio (Mar 14, 2021) 49.88
Short % of Float (Mar 14, 2021) 420.67%
Short % of Shares Outstanding (Mar 14, 2021) 415.04%
Shares Short (prior month Feb 11, 2021) 47.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin -220.24%
Operating Margin (ttm)-187.27%

Management Effectiveness

Return on Assets (ttm)-22.77%
Return on Equity (ttm)-191.81%

Income Statement

Revenue (ttm)83.14M
Revenue Per Share (ttm)1.81
Quarterly Revenue Growth (yoy)0.10%
Gross Profit (ttm)55.5M
EBITDA -121.53M
Net Income Avi to Common (ttm)-183.1M
Diluted EPS (ttm)-3.99
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)240.36M
Total Cash Per Share (mrq)5.12
Total Debt (mrq)225.5M
Total Debt/Equity (mrq)940.85
Current Ratio (mrq)3.18
Book Value Per Share (mrq)0.51

Cash Flow Statement

Operating Cash Flow (ttm)-64.69M
Levered Free Cash Flow (ttm)-45.54M